Quick Answer
Bolt Biotherapeutics, Inc. reported Shares Outstanding of 1.92 million shares for fiscal year 2025.
Bolt Biotherapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.92M | +0.2% |
| 2024 | 1.92M | -95.0% |
| 2023 | 38.11M | +0.8% |
| 2022 | 37.80M | +1.1% |
| 2021 | 37.40M | +1655.7% |
| 2020 | 2.13M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.92M | -95.0% | +0.0% |
| June 30, 2025 | 1.92M | -95.0% | -95.0% |
| March 31, 2025 | 38.34M | +0.6% | +1900.0% |
| December 31, 2024 | 1.92M | -95.0% | -95.0% |
| September 30, 2024 | 38.27M | +0.8% | +0.0% |
| June 30, 2024 | 38.26M | +0.8% | +0.4% |
| March 31, 2024 | 38.13M | +0.8% | +0.0% |
| December 31, 2023 | 38.11M | +0.8% | +0.4% |
- Bolt Biotherapeutics, Inc. showed an increase of +0.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Bolt Biotherapeutics, Inc.’s shares outstanding has declined by 9.8% (from 2.13 million shares to 1.92 million shares).
- The most recent figure is from Bolt Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: